Terns Pharmaceuticals

IPO

Home - Terns Pharma

Employees
51–200
Business Model
B2B
Type
Public

About

Clinical-stage biopharmaceutical company developing small-molecule therapies for serious diseases including NASH and hematologic cancers.

Tech & App Stack

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

View pricing

Similar Companies